Peter H. Sayre

8.1k citations

45 papers · 5.0k indexed · 2 hit papers · h-index 29

Immunology and Allergy top 0.2%
Surgery top 2%
Immunology top 2%
Genetics top 2%
Physiology top 5%

Co-authors: Graham Roberts Marshall Plaut George Du Toit Gideon Lack Henry T. Bahnson Suzana Radulović Victor Turcanu Deborah Phippard
Topics: Monoclonal and Polyclonal Antibodies Research (10 papers)T-cell and B-cell Immunology (8 papers)Immune Cell Function and Interaction (7 papers)
Cited by: Immunology and Allergy Transplantation Immunology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States United Kingdom Canada

In The Last Decade

Peter H. Sayre

45 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy

2015 1.3k citations George Du Toit, Graham Roberts et al. New England Journal of Medicine profile →
Type 1 diabetes immunotherapy using polyclonal regulatory T cells

2015 810 citations Jeffrey A. Bluestone, Stephen E. Gitelman et al. profile →

Peers

Countries citing papers authored by Peter H. Sayre

Since Specialization

Citations

This map shows the geographic impact of Peter H. Sayre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Sayre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Sayre more than expected).

Fields of papers citing papers by Peter H. Sayre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Sayre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Sayre. The network helps show where Peter H. Sayre may publish in the future.

Co-authorship network of co-authors of Peter H. Sayre

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Sayre. A scholar is included among the top collaborators of Peter H. Sayre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Sayre. Peter H. Sayre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomarkers of severity and threshold of allergic reactions during oral peanut challenges 2020 ·Journal of Allergy and Clinical Immunology ·Alexandra F. Santos,George Du Toit,Colin O’Rourke,Natalia Bécares,Natália C. Couto-Francisco,Suzana Radulović,Ekaterina Khaleva,Monica Basting,Kristina M. Harris,David Larson,Peter H. Sayre,Marshall Plaut,Graham Roberts,Henry T. Bahnson,Gideon Lack	103
2	Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients 2018 ·Hepatology ·Vadim Jucaud,Abraham Shaked,Michele Desmarais,Peter H. Sayre,Sandy Feng,Josh Levitsky,Matthew J. Everly	46
3	ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis 2016 ·Multiple Sclerosis Journal ·Samia J. Khoury,James Rochon,Linna Ding,M. Byron,(unknown),Patti Tosta,Wendy Gao,Mark S. Freedman,Douglas L. Arnold,Peter H. Sayre,Dawn E. Smilek,(unknown)	42
4	An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection 2016 ·Hepatology ·Abraham Shaked,Bao‐Li Chang,Michael R. Barnes,Peter H. Sayre,Leslie A. Lange,Smita Asare,Michele Desmarais,Michael V. Holmes,Toumy Guettouche,Brendan J. Keating	47
5	Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Gabriel N. Mannis,Thomas Martin,Lloyd E. Damon,Charalambos Andreadis,Rebecca L. Olin,Katherine A. Kong,Malek Faham,Jimmy J. Hwang,Weiyun Z. Ai,Karin Gaensler,Peter H. Sayre,Jeffrey L. Wolf,Aaron C. Logan	9
6	Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States 2015 ·American Journal of Transplantation ·Daniel C. Brennan,Heather Kopetskie,Peter H. Sayre,Rodolfo Alejandro,Enrico Cagliero,A. M. James Shapiro,Julia Goldstein,Michele Desmarais,Susan Booher,Peter J. Bianchine	119
7	Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission 2015 ·Leukemia & lymphoma ·Gabriel N. Mannis,Thomas G. Martin,Lloyd E. Damon,Aaron C. Logan,Rebecca L. Olin,Michael Flanders,Weiyun Z. Ai,Karin Gaensler,Lawrence D. Kaplan,Peter H. Sayre,Catherine C. Smith,Jeffrey L. Wolf,Charalambos Andreadis	8
8	A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid Leukemia 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Gabriel N. Mannis,Charalambos Andreadis,Aaron C. Logan,Lloyd E. Damon,Leslie Z. Benet,Weiyun Z. Ai,Karin Gaensler,Lawrence D. Kaplan,(unknown),Charles Linker,Rebecca L. Olin,Peter H. Sayre,Catherine C. Smith,(unknown),Jeffrey M. Venstrom,Jeffrey L. Wolf,Thomas G. Martin	2
9	Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergybreakdown → 2015 ·New England Journal of Medicine ·George Du Toit,Graham Roberts,Peter H. Sayre,Henry T. Bahnson,Suzana Radulović,Alexandra F. Santos,Helen A. Brough,Deborah Phippard,Monica Basting,Mary Feeney,Victor Turcanu,Michelle L. Sever,(unknown),Marshall Plaut,Gideon Lack	1307
10	Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial 2013 ·The Lancet Diabetes & Endocrinology ·Stephen E. Gitelman,Peter A. Gottlieb,Mark Rigby,Eric I. Felner,Steven M. Willi,Lynda K. Fisher,Antoinette Moran,Michael Gottschalk,Wayne V. Moore,Ashley Pinckney,Lynette Keyes-Elstein,Sudeepta Aggarwal,Deborah Phippard,Peter H. Sayre,Linna Ding,Jeffrey A. Bluestone,Mario R. Ehlers	97
11	Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy 2009 ·Journal of Autoimmunity ·Tihamer Orban,Klára Farkas,Heyam Jalahej,(unknown),András Treszl,Ben Falk,Helena Reijonen,Joseph I. Wolfsdorf,Alyne Ricker,Jeffrey B. Matthews,(unknown),Peter H. Sayre,(unknown)	94
12	Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years 2009 ·Clinical Immunology ·Kevan C. Herold,Stephen E. Gitelman,Carla J. Greenbaum,Jennifer M. Puck,William Hagopian,Peter A. Gottlieb,Peter H. Sayre,Peter J. Bianchine,Emelita L. Wong,Vicki Seyfert‐Margolis,Kasia Bourcier,Jeffrey A. Bluestone	163
13	Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase11Abbreviations: BVdU, (E)-5-(2-bromovinyl)-2′-deoxyuridine; BVdUMP, (E)-5-(2-bromovinyl)-2′-deoxyuridine 5′-monophosphate; NB1011, (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl l-methoxyalaninylphosphoramidate; COSY, correlated spectroscopy; DCI, direct current ionization; DMF, N,N-dimethylformamide; dUMP, 2′-deoxyuridine 5′-monophosphate; ECTA, enzyme-catalyzed therapeutic agent; 5-FU, 5-fluorouracil; 5-FdUMP, 5-fluoro-2′-deoxyuridine 5′-monophosphate; RFU, relative fluorescence units; THF, N5,N10-methylene tetrahydrofolate; TBDMS, tert-butyldimethylsilyl; and TS, thymidylate synthase (EC 2.1.1.45). 2001 ·Biochemical Pharmacology ·(unknown),Michael P. Groziak,Maria V. Sergeeva,Malgorzata Beryt,Christopher R. Boyer,Robert M. Stroud,Peter H. Sayre,John W. Park,Patrick Johnston,Dennis J. Slamon,H. Michael Shepard,Mark D. Pegram	29
14	Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases 2001 ·Journal of Molecular Biology ·Peter H. Sayre,Janet Finer-Moore,Timothy A. Fritz,(unknown),Susan B. Gates,W.C. MacKellar,Vinod F. Patel,R. M. Stroud	55
15	Autologous stem cell transplantation for acute myeloid leukemia in first remission 2000 ·Biology of Blood and Marrow Transplantation ·Charles Linker,Curt A. Ries,Lloyd E. Damon,Peter H. Sayre,Willis H. Navarro,Hope S. Rugo,Arnold D. Rubin,Delvyn C. Case,Pamela Crilley,David Topolsky,Isadore Brodsky,(unknown),Jeffrey L. Wolf	45
16	ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis 1997 ·Oncogene ·Chuan-Hsiung Chang,Gary K. Scott,Wen-Lin Kuo,Xiaohui Xiong,(unknown),John W. Park,Peter H. Sayre,Katrina Erny-Albrecht,Colin C. Collins,Joe W. Gray,Christopher C. Benz	151
17	The Structural Biology of CD2 1989 ·Immunological Reviews ·Philippe Moingeon,Hsiu‐Ching Chang,Peter H. Sayre,Linda K. Clayton,Andrés Alcover,Phyllis Gardner,Ellis L. Reinherz	131
18	Structural and binding analysis of a two domain extracellular CD2 molecule. 1989 ·The Journal of Experimental Medicine ·Peter H. Sayre,Rebecca E. Hussey,(unknown),Thomas L. Ciardelli,Ellis L. Reinherz	51
19	The T11 (CD2) cDNA encodes a transmembrane protein which expresses T11₁, T11₂ and T11₃ epitopes but which does not independently mediate calcium influx: analysis by gene transfer in a baculovirus system 1988 ·European Journal of Immunology ·Andrés Alcover,Hsiu‐Ching Chang,Peter H. Sayre,Rebecca E. Hussey,Ellis L. Reinherz	14
20	Murine and human T11 (CD2) cDNA sequences suggest a common signal transduction mechanism 1987 ·European Journal of Immunology ·Linda K. Clayton,Peter H. Sayre,Jiří Novotný,Ellis L. Reinherz	38

About Peter H. Sayre

Peter H. Sayre is a scholar working on Transplantation, Immunology and Allergy and Hematology, having authored 45 papers that have together received 5.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Immunology and Allergy (1.7k citations), Transplantation (307 citations) and Immunology (1.4k citations). Peter H. Sayre has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Graham Roberts, Marshall Plaut, George Du Toit, Gideon Lack, Henry T. Bahnson, Suzana Radulović, Victor Turcanu, Deborah Phippard, Alexandra F. Santos and Monica Basting. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact